Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
Xu Y, Vasiljevic E, Deming YK, Jonaitis EM, Koscik RL, Van Hulle CA, Lu Q, Carboni M, Kollmorgen G, Wild N, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Engelman CD. Xu Y, et al. Among authors: carboni m. J Alzheimers Dis. 2023;94(4):1587-1605. doi: 10.3233/JAD-230097. J Alzheimers Dis. 2023. PMID: 37482996 Free PMC article.
Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit.
Johnson SC, Suárez-Calvet M, Suridjan I, Minguillón C, Gispert JD, Jonaitis E, Michna A, Carboni M, Bittner T, Rabe C, Kollmorgen G, Zetterberg H, Blennow K. Johnson SC, et al. Among authors: carboni m. Alzheimers Res Ther. 2023 Jan 28;15(1):25. doi: 10.1186/s13195-023-01168-y. Alzheimers Res Ther. 2023. PMID: 36709293 Free PMC article.
Effect of Pathway-specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-related Biomarkers among Asymptomatic Individuals.
Xu Y, Vasiljevic E, Deming YK, Jonaitis EM, Koscik RL, Van Hulle CA, Lu Q, Carboni M, Kollmorgen G, Wild N, Carlsson CM, Johnson SC, Zetterberg H, Blennow K, Engelman CD. Xu Y, et al. Among authors: carboni m. medRxiv [Preprint]. 2023 Feb 1:2023.01.30.23285142. doi: 10.1101/2023.01.30.23285142. medRxiv. 2023. PMID: 36778431 Free PMC article. Updated. Preprint.
A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease.
Bruno D, Jauregi Zinkunegi A, Kollmorgen G, Carboni M, Wild N, Carlsson C, Bendlin B, Okonkwo O, Chin N, Hermann BP, Asthana S, Blennow K, Langhough R, Johnson SC, Pomara N, Zetterberg H, Mueller KD. Bruno D, et al. Among authors: carboni m. J Clin Exp Neuropsychol. 2023 Oct;45(8):763-769. doi: 10.1080/13803395.2023.2240060. Epub 2023 Aug 12. J Clin Exp Neuropsychol. 2023. PMID: 37571873
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
Pelkmans W, Shekari M, Brugulat-Serrat A, Sánchez-Benavides G, Minguillón C, Fauria K, Molinuevo JL, Grau-Rivera O, González Escalante A, Kollmorgen G, Carboni M, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M, Gispert JD; ALFA study. Pelkmans W, et al. Among authors: carboni m. Alzheimers Dement. 2024 Jan;20(1):483-493. doi: 10.1002/alz.13450. Epub 2023 Sep 10. Alzheimers Dement. 2024. PMID: 37690071 Free PMC article.
The potential clinical value of plasma biomarkers in Alzheimer's disease.
Blennow K, Galasko D, Perneczky R, Quevenco FC, van der Flier WM, Akinwonmi A, Carboni M, Jethwa A, Suridjan I, Zetterberg H. Blennow K, et al. Among authors: carboni m. Alzheimers Dement. 2023 Dec;19(12):5805-5816. doi: 10.1002/alz.13455. Epub 2023 Sep 11. Alzheimers Dement. 2023. PMID: 37694991 Review.
Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
Hale MR, Langhough R, Du L, Hermann BP, Van Hulle CA, Carboni M, Kollmorgen G, Basche KE, Bruno D, Sanson-Miles L, Jonaitis EM, Chin NA, Okonkwo OC, Bendlin BB, Carlsson CM, Zetterberg H, Blennow K, Betthauser TJ, Johnson SC, Mueller KD. Hale MR, et al. Among authors: carboni m. Neurobiol Aging. 2024 Jan;133:87-98. doi: 10.1016/j.neurobiolaging.2023.09.018. Epub 2023 Oct 5. Neurobiol Aging. 2024. PMID: 37925995
Lifetime Stressful Events Associated with Alzheimer's Pathologies, Neuroinflammation and Brain Structure in a Risk Enriched Cohort.
Palpatzis E, Akinci M, Aguilar-Dominguez P, Garcia-Prat M, Blennow K, Zetterberg H, Carboni M, Kollmorgen G, Wild N, Fauria K, Falcon C, Gispert JD, Suárez-Calvet M, Grau-Rivera O, Sánchez-Benavides G, Arenaza-Urquijo EM; ALFA study. Palpatzis E, et al. Among authors: carboni m. Ann Neurol. 2024 Jun;95(6):1058-1068. doi: 10.1002/ana.26881. Epub 2024 Mar 11. Ann Neurol. 2024. PMID: 38466157
Blood-based biomarkers in Alzheimer's disease: Future directions for implementation.
Suridjan I, van der Flier WM, Monsch AU, Burnie N, Baldor R, Sabbagh M, Vilaseca J, Cai D, Carboni M, Lah JJ. Suridjan I, et al. Among authors: carboni m. Alzheimers Dement (Amst). 2023 Dec 4;15(4):e12508. doi: 10.1002/dad2.12508. eCollection 2023 Oct-Dec. Alzheimers Dement (Amst). 2023. PMID: 38058357 Free PMC article.
326 results